AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo.
about
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewDevelopments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling.Zyxin regulates migration of renal epithelial cells through activation of hepatocyte nuclear factor-1βAmplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells.The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer.50 years of The FEBS Journal: looking back as well as ahead.
P2860
AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivo.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
AKT signalling is required for ...... μ-Myc B-cell lymphoma in vivo.
@en
AKT signalling is required for ...... μ-Myc B-cell lymphoma in vivo.
@nl
type
label
AKT signalling is required for ...... μ-Myc B-cell lymphoma in vivo.
@en
AKT signalling is required for ...... μ-Myc B-cell lymphoma in vivo.
@nl
prefLabel
AKT signalling is required for ...... μ-Myc B-cell lymphoma in vivo.
@en
AKT signalling is required for ...... μ-Myc B-cell lymphoma in vivo.
@nl
P2093
P2860
P50
P356
P1433
P1476
AKT signalling is required for ...... μ-Myc B-cell lymphoma in vivo.
@en
P2093
Jennifer R Devlin
Katherine M Hannan
Megan J Bywater
Richard B Pearson
P2860
P304
P356
10.1111/FEBS.12135
P407
P577
2013-02-13T00:00:00Z